The utility of serum soluble st2 measured at discharge in prognostication of late ventricular adverse remodeling in patients with st-segment elevation myocardial infarction

2 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention Biomarkers ACVC Premium Access Acute Cardiovascular Care 2019

ESC 365 is supported by

ESC 365 is supported by